Fleming John Turman 4

What Happened John T. Fleming, a director of USANA Health Sciences (USNA), sold 2,450 shares in an open-market transaction on June 1, 2026. The shares were sold at $17.93 per share for a total transaction value of $43,929. This was a sale (S), which is often routine insider liquidity rather than a direct signal about company performance.

Key Details

• Transaction date and price: 2026-06-01 — open-market sale of 2,450 shares at $17.93 each.
• Total proceeds: $43,929.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Transaction code: S (Sale).
• Filing timeliness: report filed on 2026-06-01 (same-day filing shown), indicating a timely Form 4 in the provided record.
• No footnotes, 10b5-1 plan, tax-withholding, or option-exercise details were noted in the supplied data.

Context

• "S" denotes a sale of existing shares; unlike purchases, sales are commonly for personal liquidity or portfolio management and do not necessarily reflect insider views on company prospects.
• This transaction was a straightforward open-market sale (not an option exercise, gift, or award).